Source:http://linkedlifedata.com/resource/pubmed/id/18230340
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2008-2-15
|
pubmed:abstractText |
The products of the TSC1 (hamartin) and TCS2 (tuberin) tumor suppressor genes negatively regulate cell growth by inhibiting mTOR signaling. Recent research has led to the postulation that tuberin and/or hamartin are involved in tumor migration, presumably through Rho activation. Here we show that LEF-8 cells, which contain a Y1571 missense mutation in tuberin, express higher Rac1 activity than tuberin negative and positive cells. We also provide evidence of obvious lamellipodia formation in LEF-8 cells. Since the production of TSC2(Y1571H) cannot form a hetero-complex with hamartin, we further analyzed another mutant, TSC2(R611Q), which also lacks the ability to form a complex with hamartin. Introducing both forms of mutated TSC2 into COS-1 cells increased Rac1 activity as well as cell motility. We also found these two mutants interacted with Rac1. We further demonstrated that the introduction of mutated TSC2 into COS-1 cells can generate higher reactive oxygen species (ROS). These results indicate that loss-of-function mutated tuberin can activate Rac1 and thereby increase ROS production.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Reactive Oxygen Species,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/rac1 GTP-Binding Protein,
http://linkedlifedata.com/resource/pubmed/chemical/tuberous sclerosis complex 2 protein
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1090-2104
|
pubmed:author |
pubmed-author:DasSwadesh KSK,
pubmed-author:HinoOkioO,
pubmed-author:InoueHirohumiH,
pubmed-author:KazamiMachikoM,
pubmed-author:KobayashiKen-IchiK,
pubmed-author:KobayashiToshiyukiT,
pubmed-author:SuzukiTsukasaT,
pubmed-author:TadokoroTadahiroT,
pubmed-author:YamamotoYujiY,
pubmed-author:YeungRaymond SRS
|
pubmed:issnType |
Electronic
|
pubmed:day |
28
|
pubmed:volume |
368
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
132-7
|
pubmed:meshHeading |
pubmed-meshheading:18230340-Animals,
pubmed-meshheading:18230340-Cell Line,
pubmed-meshheading:18230340-Cell Movement,
pubmed-meshheading:18230340-Cercopithecus aethiops,
pubmed-meshheading:18230340-Enzyme Activation,
pubmed-meshheading:18230340-Mice,
pubmed-meshheading:18230340-Mutation,
pubmed-meshheading:18230340-Protein Binding,
pubmed-meshheading:18230340-Rats,
pubmed-meshheading:18230340-Reactive Oxygen Species,
pubmed-meshheading:18230340-Tumor Suppressor Proteins,
pubmed-meshheading:18230340-rac1 GTP-Binding Protein
|
pubmed:year |
2008
|
pubmed:articleTitle |
Tuberous sclerosis complex 2 loss-of-function mutation regulates reactive oxygen species production through Rac1 activation.
|
pubmed:affiliation |
Department of Applied Biology and Chemistry, Tokyo University of Agriculture, 1-1-1 Sakuragaoka, Setagaya-ku, Tokyo 156-8502, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|